1-9 of 9
Janusz Blasiak
Close
Sort by
Journal Articles

BCR-ABL1 Kinase Inhibits DNA Glycosylases to Enhance Oxidative DNA Damage and Stimulate Genomic Instability

Artur Slupianek, PhD, Rafal Falinski, PhD, Pawel Znojek, Tomasz Stoklosa, MD, PhD, Sylwia Flis, Valentina Doneddu, Ewelina Synowiec, Janusz Blasiak, Alfonso Bellacosa, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 520.
https://doi.org/10.1182/blood.V120.21.520.520
Published: 2012
Journal Articles

BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.

Tomasz Stoklosa, MD, PhD, Tomasz Poplawski, PhD, Grzegorz Basak, MD, PhD, Artur Slupianek, PhD, Janusz Blasiak, PhD, Ilona Seferynska, MD, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 32.
https://doi.org/10.1182/blood.V110.11.32.32
Published: 2007
Journal Articles

BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance

Mateusz Koptyra, Rafal Falinski, Michal O. Nowicki, Tomasz Stoklosa, Ireneusz Majsterek, Margaret Nieborowska-Skorska, Janusz Blasiak, Tomasz Skorski
Journal: Blood
Blood (2006) 108 (1): 319–327.
https://doi.org/10.1182/blood-2005-07-2815
Published: 2006
Includes: Supplemental data
Journal Articles

Imatinib Mesylate (STI571) Abrogates the Resistance to Doxorubicin in K562 Chronic Myeloid Leukemia Cells by Inhibition of BCR/ABL Kinase-Mediated DNA Repair.

Ireneusz Majsterek, PhD, Janusz Blasiak, PhD, Artur Slupianek, PhD, Tomasz Skorski, PhD
Journal: Blood
Blood (2005) 106 (11): 1525.
https://doi.org/10.1182/blood.V106.11.1525.1525
Published: 2005
Journal Articles

ATR-Chk1 Axis Is Activated, but the Function of Chk1 Is Disrupted in BCR/ABL Leukemia Cells Responding to DNA Damage.

Margaret Nieborowska, MD, PhD, Tomasz Stoklosa, MD, PhD, Mandrita Datta, Agnieszka Czechowska, Lori Rink, Janusz Blasiak, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2883.
https://doi.org/10.1182/blood.V106.11.2883.2883
Published: 2005
Journal Articles

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks

Michal O. Nowicki, Rafal Falinski, Mateusz Koptyra, Artur Slupianek, Tomasz Stoklosa, Ewa Gloc, Margaret Nieborowska-Skorska, Janusz Blasiak, Tomasz Skorski
Journal: Blood
Blood (2004) 104 (12): 3746–3753.
https://doi.org/10.1182/blood-2004-05-1941
Published: 2004
Journal Articles

Imatinib (STI571) Induces DNA Damage in BCR/ABL-Expressing Leukemic Cells but Not in Normal Lymphocytes.

Janusz Blasiak, Jozef Drzewoski, Tomasz Poplawski, Agnieszka Czechowska
Journal: Blood
Blood (2004) 104 (11): 4353.
https://doi.org/10.1182/blood.V104.11.4353.4353
Published: 2004
Journal Articles

BCR/ABL Oncogenic Kinase Promotes Unfaithful Repair of the Reactive Oxygen Species - Dependent DNA Double-Strand Breaks.

Tomasz Skorski, MD, PhD, Michal O. Nowicki, MS, Rafal Falinski, MS, Mateusz Koptyra, MS, Artur Slupianek, PhD, Tomasz Stoklosa, MD, Ewa Gloc, Margaret Nieborowska-Skorska, MD, PhD, Janusz Blasiak, PhD
Journal: Blood
Blood (2004) 104 (11): 712.
https://doi.org/10.1182/blood.V104.11.712.712
Published: 2004
Journal Articles

BCR/ABL Oncogenic Kinase Stimulates DNA Oxidative Damage To Induce Self-Mutagenesis Causing Resistance to Imatinib Mesylate.

Mateusz Koptyra, MS, Rafal Falinski, MS, Michal O. Nowicki, MS, Janusz Blasiak, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 714.
https://doi.org/10.1182/blood.V104.11.714.714
Published: 2004